Grifols
Morgan Stanley buys near 25% of Grifols shares. This investment fund and Grifols family stay as Grifols main shareholders [02.01.07]
German Castejón new Grifols President and Edgar D Jannotta (William Blair) has joined the board of directors[12.01.04] +More..
MidOcean Partners and Ripplewood Holdings to merge within the next 12 months [08.12.04] +More...
Grifols ownership structure: a MidOcean's controlled company (Gabriella Holding NV) is the main shareholder (40,8%). MidOcean's investors for the largest stakes include Bregal, Ontario Teachers' Merchant Bank or NIB Capital Private Equity. [04.05.04]
Grifols improves its corporate image by announcing FDA approval of treatment of von Willebrand disease and an hemophilic meeting [03.01.07]
Grifols to sell its parenteral solutions business to Macopharma [09.26.04] +More...
Probitas postpones IPO [07.20.04] +More...
Grifols Payoff to SCH and Deutsche Bank before the IPO: 30 MM € in shares[07.20.04] +More...
It has been approved the initial public offering prospectus. Grifols set an indicative share price range of 2.7€ - 3.3 € for the offering, valuing the company between 570 MM € and 700 MM € [07.05.04] Prospectus (Part 1) (Part 2)
Grifols value not determined yet. SCH and Grifols management have different opinions. The IPO brochure is pending to be presented to the Stock Comission [06.20.04] +More...
Grifols to launch an IPO for 500 million Euros .[04.05.04] +More...
2003 Grifols Net Profit: 21,5 million euros (14% increase) [04.20.04] +More...
Grifols General meeting on May 11th.[05.01.04] +More...
Grifols managers say to Spanish health authorities that they will produce apotransferrin in 2006. Nevertheless they didn't do it [04.01.07]
Grifols managers say that they will not produce apotransferrin in 2005 [12.01.04]
Apotransferrin has shown its effectiveness: Violet Hb
raises to 12,3. Finnish Red Cross will not produce apotransferrin anymore.
Grifols could be the last chance in order to have apotransferrin
[09.26.04].
+More.
Violet receives her first apotransferrin transfusion. We will see its effectiveness the next september with new blood tests [08.03.04]
After three weeks, Grifols managers are still studying if it is possible having apotransferrin available [07.05.04]
Meeting with Grifols. The meeting was attended by doctors from the Hospital, the Blood Transfusion Service, and by Grifols managers. Grifols managers told us that they would study if it is possible having apotransferrin from april 2006 on.[06.09.04]
Grifols to give all its support to find a solution for Violet. We are currently waiting for a meeting with Mr. Javier Jorba so as to concrete the support shown by Grifols [05.20.04].
Hemoglobin 8.6 Ferritin around 1.000. Ten months and a chelation treatment in the horizon. Take a look at Hromec's article.[04.05.04]